OSLO, NORWAY--(Marketwire - March 19, 2013) - Algeta ASA (OSE: ALGETA), a company focused on
development of novel targeted cancer therapeutics, announces its Annual
Algeta's Annual General Meeting will be held on 11 April 2013 at 16:00
(CET) at the offices of Algeta ASA at Kjelsåsveien 172A, Oslo, Norway.
Please find attached the Notice of Algeta ASA's Annual General Meeting,
amended charter for the nomination committee, and attendance slip and proxy
form. These are, together with the annual report, also available on
www.algeta.com in the Investor section.
Algeta is a company focused on developing novel targeted therapies for
with cancer based on its alpha-pharmaceutical platform. The Company is
headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC,
Cambridge, MA performing commercial marketing operations in the US. Algeta
listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information
Notice of Attendance of Annual General Meeting in Algeta ASA:
Attendance and proxy form:
Proposed amended charter for the Nomination Committee:
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Algeta ASA via Thomson Reuters ONE